Cargando…

Colocalization of Interferon Regulatory Factor 7 (IRF7) with Latent Membrane Protein 1 (LMP1) of Epstein-Barr Virus

Interferon regulatory factor 7 (IRF7) is one of the transcriptional factors for the activation of type I Interferon (IFN) genes. It is known that IRF7 and the latent membrane protein 1 (LMP1) of Epstein-Barr virus (EBV) are highly expressed in EBV type III latency cells, and LMP1 induces mRNA expres...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, In-Wook, Park, Ho-Sun
Formato:	Texto
Lenguaje:	English
Publicado:	The Korean Academy of Medical Sciences 2006
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2729938/ https://www.ncbi.nlm.nih.gov/pubmed/16778376 http://dx.doi.org/10.3346/jkms.2006.21.3.379

Ejemplares similares

NF-κB and IRF7 Pathway Activation by Epstein-Barr Virus Latent Membrane Protein 1
por: Ersing, Ina, et al.
Publicado: (2013)

Overexpression of Epstein-Barr virus-encoded latent membrane protein-1 (LMP-1) in oral squamous cell carcinoma
por: Rahman, Rifat, et al.
Publicado: (2019)

Id1 Interacts and Stabilizes the Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) in Nasopharyngeal Epithelial Cells
por: Hau, Pok Man, et al.
Publicado: (2011)

A Systematic Review of Epstein–Barr Virus Latent Membrane Protein 1 (LMP1) Gene Variants in Nasopharyngeal Carcinoma
por: Banko, Ana, et al.
Publicado: (2021)

Therapeutic vaccine targeting Epstein-Barr virus latent protein, LMP1, suppresses LMP1-expressing tumor growth and metastasis in vivo
por: Lin, Mei-Chun, et al.
Publicado: (2017)

Interleukins, laminin and epstein - barr virus latent membrane protein 1 (EBV LMP1) Promote metastatic phenotype in nasopharyngeal carcinoma
por: Chew, Michelle MS, et al.
Publicado: (2010)

Epstein-Barr Virus Latent Membrane Protein-1 Induces the Expression of SUMO-1 and SUMO-2/3 in LMP1-positive Lymphomas and Cells
por: Salahuddin, Sadia, et al.
Publicado: (2019)

Epstein-Barr Virus LMP1 Modulates the CD63 Interactome
por: Cheerathodi, Mujeeb, et al.
Publicado: (2021)

Toll-Like Receptor 7 Stimulates the Expression of Epstein-Barr Virus Latent Membrane Protein 1
por: Valente, Robert M., et al.
Publicado: (2012)

Transcriptome Changes Induced by Epstein-Barr Virus LMP1 and LMP2A in Transgenic Lymphocytes and Lymphoma
por: Shair, Kathy H. Y., et al.
Publicado: (2012)

Epstein-Barr Virus Latent Membrane Protein 2a (Lmp2a) Employs the Slp-65 Signaling Module
por: Engels, Niklas, et al.
Publicado: (2001)

The signaling pathways of Epstein-Barr virus-encoded latent membrane protein 2A (LMP2A) in latency and cancer
por: Pang, Mei-Fong, et al.
Publicado: (2008)

Epstein-Barr virus Latent Membrane Protein LMP1 reduces p53 protein levels independent of the PI3K-Akt pathway
por: Husaini, Roslina, et al.
Publicado: (2011)

The copy number of Epstein-Barr virus latent genome correlates with the oncogenicity by the activation level of LMP1 and NF-κB
por: Zuo, Lielian, et al.
Publicado: (2015)

Epstein-Barr virus latent membrane protein-1 (LMP-1) 30-bp deletion and Xho I-loss is associated with type III nasopharyngeal carcinoma in Malaysia
por: See, Hui Shien, et al.
Publicado: (2008)

Activation of sterol regulatory element‐binding protein 1 (SREBP1)‐mediated lipogenesis by the Epstein–Barr virus‐encoded latent membrane protein 1 (LMP1) promotes cell proliferation and progression of nasopharyngeal carcinoma
por: Lo, Angela Kwok‐Fung, et al.
Publicado: (2018)

Evaluation of LMP1 of Epstein-Barr virus as a therapeutic target by its inhibition
por: Hannigan, Adele, et al.
Publicado: (2010)

The Role of Epstein-Barr Virus LMP-1 Immunohistochemical Staining in Childhood Hodgkin Lymphoma
por: Tanyildiz, Hikmet Gulsah, et al.
Publicado: (2015)

Epstein–Barr Virus LMP1 Induces Soluble PD-L1 in Nasopharyngeal Carcinoma
por: Kase, Kina, et al.
Publicado: (2021)

The EBV-encoded Latent Membrane Proteins, LMP2A and LMP2B, Limit the Actions of Interferon by Targeting Interferon Receptors for Degradation
por: Shah, Khilan M., et al.
Publicado: (2009)

Heat Shock Protein 90 Inhibitors Repress Latent Membrane Protein 1 (LMP1) Expression and Proliferation of Epstein-Barr Virus-Positive Natural Killer Cell Lymphoma
por: Murata, Takayuki, et al.
Publicado: (2013)

The Epstein-Barr virus latent membrane protein-1 (LMP1) 30-bp deletion and XhoI-polymorphism in nasopharyngeal carcinoma: a meta-analysis of observational studies
por: da Costa, Vivaldo G, et al.
Publicado: (2015)

Interferon Regulatory Factors IRF1 and IRF7 Directly Regulate Gene Expression in Bats in Response to Viral Infection
por: Irving, Aaron T., et al.
Publicado: (2020)

Epstein–Barr virus LMP2A imposes sensitivity to apoptosis
por: Swanson-Mungerson, Michelle, et al.
Publicado: (2010)

Characterization of a Suppressive Cis-acting Element in the Epstein–Barr Virus LMP1 Promoter
por: Yoshida, Masahiro, et al.
Publicado: (2017)

Differential Signaling and Tumor Necrosis Factor Receptor–Associated Factor (Traf) Degradation Mediated by Cd40 and the Epstein-Barr Virus Oncoprotein Latent Membrane Protein 1 (Lmp1)
por: Brown, Kevin D., et al.
Publicado: (2001)

Epstein-Barr Virus LMP2A Reduces Hyperactivation Induced by LMP1 to Restore Normal B Cell Phenotype in Transgenic Mice
por: Vrazo, Alexandra C., et al.
Publicado: (2012)

Epstein-Barr Virus Latent Membrane Protein-1 Expression in Nasopharyngeal Carcinoma
por: Salano, Valerie E., et al.
Publicado: (2021)

Detection of Epstein Barr Nuclear Antigen-1 (EBNA-1), Early Antigen 1F, 2R (EA-1F, EA- 2R) along with Epstein–Barr virus Latent Membrane Protein 1 (LMP1) in Breast Cancer of Northern India: An Interim Analysis
por: Shahi, Vanshika, et al.
Publicado: (2022)

C-Terminal Region of EBNA-2 Determines the Superior Transforming Ability of Type 1 Epstein-Barr Virus by Enhanced Gene Regulation of LMP-1 and CXCR7
por: Cancian, Laila, et al.
Publicado: (2011)

Changes in Expression Induced by Epstein-Barr Virus LMP1-CTAR1: Potential Role of bcl3
por: Edwards, Rachel Hood, et al.
Publicado: (2015)

The Epstein-Barr Virus Oncoprotein, LMP1, Regulates the Function of SENP2, a SUMO-protease
por: Selby, Thomas L., et al.
Publicado: (2019)

Dual Functions of Interferon Regulatory Factors 7C in Epstein-Barr Virus–Mediated Transformation of Human B Lymphocytes
por: Zhao, Yong, et al.
Publicado: (2010)

Vaccination against Epstein–Barr Latent Membrane Protein 1 Protects against an Epstein–Barr Virus-Associated B Cell Model of Lymphoma
por: Soo Hoo, Wesley I., et al.
Publicado: (2023)

LMP1(+)SLAMF1(high) cells are associated with drug resistance in Epstein-Barr virus-positive Farage cells
por: Yoon, Heejei, et al.
Publicado: (2017)

Epstein–Barr virus latent genes
por: Kang, Myung-Soo, et al.
Publicado: (2015)

Targeting Epstein–Barr virus oncoprotein LMP1-mediated glycolysis sensitizes nasopharyngeal carcinoma to radiation therapy
por: Xiao, L, et al.
Publicado: (2014)

Detection of Epstein-Barr Virus by PCR and Expression of LMP1, p53, CD44 in Gastric Cancer
por: Lee, Myung Ah, et al.
Publicado: (2004)

Epstein–Barr Virus Epidemiology, Serology, and Genetic Variability of LMP-1 Oncogene Among Healthy Population: An Update
por: Smatti, Maria K., et al.
Publicado: (2018)

Molecular Screening for Epstein-Barr virus (EBV): Detection of Genomic EBNA-1, EBNA-2, LMP-1, LMP-2 Among Vietnamese Patients with Nasopharyngeal Brush Samples
por: Lao, Thuan Duc, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_nieqctitf0vdsi1dj0agtg1v59